The role of estrogen in bipolar disorder, a review

References

• Kulkarni J, Garland KA, Scaffidi A, Headey B, Anderson R, de Castella A, et al. A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder. Psychoneuroendocrinology. 2006;31:543–7.
   PubMed Web of Science ®Google Scholar
• Zarate CA Jr, Singh JB, Carlson PJ, Quiroz J, Jolkovsky L, Luckenbaugh DA, et al. Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: A pilot study. Bipolar Disord 2007;9:561–70.
   PubMed Web of Science ®Google Scholar
• Kawa I, Carter JD, Joyce PR, Doughty CJ, Frampton CM, Wells JE, et al. Gender differences in bipolar disorder: Age of onset, course, comorbidity, and symptom presentation. Bipolar Disord 2005;7:119–25.
   PubMed Web of Science ®Google Scholar
• Diflorio A, Jones I. Is sex important? Gender differences in bipolar disorder. Int Rev Psychiatry 2010;22:437–52.
   PubMed Web of Science ®Google Scholar
• Payne JL. The role of estrogen in mood disorders in women. Int Rev Psychiatry 2003;15:280–90.
   PubMed Web of Science ®Google Scholar
• Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8–19.
   PubMed Web of Science ®Google Scholar
• Kessing LV. Gender differences in the phenomenology of bipolar disorder. Bipolar Disord 2004;6:421–5.
   PubMed Web of Science ®Google Scholar
• Kessing LV. The prevalence of mixed episodes during the course of illness in bipolar disorder. Acta Psychiatr Scand 2008;117:216–24.
   PubMed Web of Science ®Google Scholar
• Baldassano CF, Marangell LB, Gyulai L, Ghaemi SN, Joffe H, Kim DR, et al. Gender differences in bipolar disorder: Retrospective data from the first 500 STEP-BD participants. Bipolar Disord. 2005;7:465–70.
   PubMed Web of Science ®Google Scholar
• Munk-Olsen T, Laursen TM, Pedersen CB, Mors O, Mortensen PB. New parents and mental disorders: A population-based register study. JAMA 2006;296:2582–9.
   PubMed Web of Science ®Google Scholar
• Douma SL, Husband C, O’Donnell ME, Barwin BN, Woodend AK. Estrogen-related mood disorders: Reproductive life cycle factors. ANS Adv Nurs Sci 2005;28:364–75.
   PubMed Web of Science ®Google Scholar
• Wieck A, Kumar R, Hirst AD, Marks MN, Campbell IC, Checkley SA. Increased sensitivity of dopamine receptors and recurrence of affective psychosis after childbirth. BMJ 1991;303:613–6.
   PubMed Web of Science ®Google Scholar
• Wieck A, Davies RA, Hirst AD, Brown N, Papadopoulos A, Marks MN, et al. Menstrual cycle effects on hypothalamic dopamine receptor function in women with a history of puerperal bipolar disorder. J Psychopharmacol 2003;17:204–9.
   PubMed Web of Science ®Google Scholar
• Yildiz A, Guleryuz S, Ankerst DP, Ongür D, Renshaw PF. Protein kinase C inhibition in the treatment of mania: A double-blind, placebo-controlled trial of tamoxifen. Arch Gen Psychiatry 2008;65:255–63.
   PubMed Web of Science ®Google Scholar
• Amrollahi Z, Rezaei F, Salehi B, Modabbernia AH, Maroufi A, Esfandiari GR, et al. Double-blind, randomized, placebo- controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania. J Affect Disord 2011;129:327–31.
   PubMed Web of Science ®Google Scholar
• Maximov PY, Lee TM, Jordan VC. The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice. Curr Clin Pharmacol 2012 Oct 4.
   Google Scholar
• O’Regan RM, Jordan VC. The evolution of tamoxifen therapy in breast cancer: Selective oestrogen-receptor modulators and downregulators. Lancet Oncol 2002;3:207–14.
   PubMed Web of Science ®Google Scholar
• Love RR, Mazess RB, Barden HS, Epstein S, Newcomb PA, Jordan VC, et al. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med 1992;326:852–6.
   PubMed Web of Science ®Google Scholar
• Cyr M, Landry M, Di Paolo T. Modulation by estrogen-receptor directed drugs of 5-hydroxytryptamine-2A receptors in rat brain. Neuropsychopharmacology 2000;23:69–78.
   PubMedGoogle Scholar
• Ahokas A, Aito M. Role of estradiol in puerperal psychosis. Psychopharmacology 1999;147:108–10.
   PubMedGoogle Scholar
• Ahokas A, Aito M, Rimón R. Positive treatment effect of estradiol in postpartum psychosis: A pilot study. J Clin Psychiatry 2000;61:166–9.
   PubMed Web of Science ®Google Scholar
• Marsh WK, Templeton A, Ketter TA, Rasgon NL. Increased frequency of depressicve episodes during the menopausal transition in women with bipolar disorder: Preliminary report. Psychiatr Res 2008;42:247–51.
   Google Scholar
• Marsh WK, Ketter TA, Crawford SL, Johnson JV, Kroll- Desrosiers AR, Rothschild AJ. Progression of female reproductive stages associated with bipolar illness exacerbation. Bipol Disord 2012;14:515–26. DOI: 10.1111/j.1399-5618.2012.01026.x.
   PubMedGoogle Scholar
• Kessing LV, Søndergård L, Kvist K, Andersen PK. Adherence to lithium in naturalistic settings: Results from a nationwide pharmacoepidemiological study. Bipolar Disord 2007;9:730–6.
   PubMed Web of Science ®Google Scholar
• Cohen I, Figer A, Tepper R, Shapira J, Altaras MM, Yigael D, et al. Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: Comparison between tamoxifen-treated and nontreated breast cancer patients. Gynecol Oncol 1999;72:202–7.
   PubMedGoogle Scholar
• Willcox DL, Yovich JL, McColm SC, Phillips JM. Progesterone, cortisol and oestradiol-17 beta in the initiation of human parturition: Partitioning between free and bound hormone in plasma. Br J Obstet Gynaecol. 1985;92:65–71.
   PubMedGoogle Scholar
• Cushman M, Kuller LH, Prentice R, Rodabough RJ, Psaty BM, Stafford RS, et al. For the Women's Health Initiative Investigators. Estrogen plus progestin and risk of venous thrombosis. JAMA 2004;292:1573–1580.
   PubMed Web of Science ®Google Scholar